183 related articles for article (PubMed ID: 37189104)
1. Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients.
Zhao M; Chandra A; Xu J; Li J
BMC Ophthalmol; 2023 May; 23(1):215. PubMed ID: 37189104
[TBL] [Abstract][Full Text] [Related]
2. Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents.
Fabinyi DC; O'Neill EC; Connell PP; Clark JB
Clin Exp Ophthalmol; 2011 Dec; 39(9):878-84. PubMed ID: 21631675
[TBL] [Abstract][Full Text] [Related]
3. [Vitreous hemorrhages in proliferative diabetic retinopathy treated with pars plana vitrectomy--own material].
Kanclerz P; Pyrzanowska-Sumita J; Murawska J; Raczyńska D; Gebka A
Klin Oczna; 2013; 115(4):291-5. PubMed ID: 24908919
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of cases with postoperative vitreous hemorrhage after 25-gauge vitrectomy for repair of proliferative diabetic retinopathy.
Sato T; Tsuboi K; Nakashima H; Emi K
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):665-671. PubMed ID: 27770210
[TBL] [Abstract][Full Text] [Related]
5. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
6. Late postoperative vitreous cavity hemorrhage after vitrectomy for proliferative diabetic retinopathy-observation versus intervention.
Brar AS; Behera UC; Karande S; Kanakagiri A; Sugumar S; Rani PK; Vignesh TP; Manayath G; Salian R; Giridhar A; Indurkhya S; Bhattacharjee H; Raman R; Sivaprasad S
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S22-S26. PubMed ID: 38131537
[TBL] [Abstract][Full Text] [Related]
7. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
8. Predictors of postoperative bleeding after vitrectomy for vitreous hemorrhage in patients with diabetic retinopathy.
Motoda S; Shiraki N; Ishihara T; Sakaguchi H; Kabata D; Takahara M; Kimura T; Kozawa J; Imagawa A; Nishida K; Shintani A; Iwahashi H; Shimomura I
J Diabetes Investig; 2018 Jul; 9(4):940-945. PubMed ID: 29265703
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
Brown JS; Mahmoud TH
Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
[TBL] [Abstract][Full Text] [Related]
10. Endodiathermy plus photocoagulation as treatment of sclerotomy site vascularization secondary to pars plana vitrectomy for proliferative diabetic retinopathy.
Nadal J; Carreras E; Canut MI
Retina; 2012 Jul; 32(7):1310-5. PubMed ID: 22466471
[TBL] [Abstract][Full Text] [Related]
11. Visual outcomes and complications following one-way air-fluid exchange technique for vitreous hemorrhage post vitrectomy in proliferative diabetic retinopathy patients.
Wang Q; Zhao J; Xu Q; Han C; Hou B; Huang Y
BMC Ophthalmol; 2021 Mar; 21(1):129. PubMed ID: 33750339
[TBL] [Abstract][Full Text] [Related]
12. Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.
Ding Y; Yao B; Hang H; Ye H
BMC Ophthalmol; 2020 Jul; 20(1):292. PubMed ID: 32677996
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
Li S; Yang Y; Zou J; Zeng J; Ding C
BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
[TBL] [Abstract][Full Text] [Related]
14. Vitreous rebleeding rate after vitrectomy or phacovitrectomy in patients with proliferative diabetic retinopathy: A retrospective study.
García-Luna S; Pita-Ortíz IY; Quevedo-Martínez JU; Somilleda-Ventura SA; Pérez-Cano HJ
Arch Soc Esp Oftalmol (Engl Ed); 2024 Feb; 99(2):62-66. PubMed ID: 38013130
[TBL] [Abstract][Full Text] [Related]
15. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.
Hershberger VS; Augsburger JJ; Hutchins RK; Raymond LA; Krug S
Ophthalmology; 2004 Jun; 111(6):1215-21. PubMed ID: 15177974
[TBL] [Abstract][Full Text] [Related]
16. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Qiu CY; Shi YY; Zhao HW; Gong YB; Nie C; Wang MG; Jia R; Zhao J; Wang X; Luo L
BMC Ophthalmol; 2022 Dec; 22(1):509. PubMed ID: 36550421
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage.
Yilmaz U; Akçaoğlu T; Avunduk MA; Kaya H; Parça O
Medicine (Baltimore); 2024 Jan; 103(3):e36963. PubMed ID: 38241585
[TBL] [Abstract][Full Text] [Related]
19. Ghost cell glaucoma after intravitreal bevacizumab for postoperative vitreous hemorrhage following vitrectomy for proliferative diabetic retinopathy.
Liu L; Wu WC; Yeung L; Wang NK; Kuo YH; Chao AN; Chen KJ; Chen TL; Lai CC; Hwang YS; Chen YP
Ophthalmic Surg Lasers Imaging; 2010; 41(1):72-7. PubMed ID: 20128573
[TBL] [Abstract][Full Text] [Related]
20. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
